The extracellular matrix of muscle - Implications for manipulation of the craniofacial musculature

European Journal of Oral Sciences

Volumn 109, Issue 4, 2001, Pages 209-221

  Lewis, M P ^a   Machell, J R A ^a   Hunt, N P ^a   Sinanan, A C M ^a   Tippett, H L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Collagen; Integrin; Masseter; Matrix metalloproteinase; Skeletal muscle

Indexed keywords

INTEGRIN; MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

ADAPTATION; ANIMAL; CONNECTIVE TISSUE; DISTRACTION OSTEOGENESIS; EXTRACELLULAR MATRIX; FACE MUSCLE; GROWTH, DEVELOPMENT AND AGING; HUMAN; PHYSIOLOGY; PRENATAL DEVELOPMENT; REGENERATION; REVIEW;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FACIAL MUSCLES; HUMANS; INTEGRINS; MATRIX METALLOPROTEINASES; OSTEOGENESIS, DISTRACTION; REGENERATION;

EID: 0035430267     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1034/j.1600-0722.2001.00021.x     Document Type: Review

References (142)

1. GOLDSPINK G. Cellular and molecular aspects of muscle growth, adaptation and ageing. Gerodont 1998; 15: 35-43.
2. SCIOTE JJ, MORRIS TJ. Skeletal muscle function and fibre types: the relationship between occlusal function and the phenotype of jaw-closing muscles in human. J Orthod 2000; 27: 15-30.
3. HUNT NP. Muscle function and the control of facial form. In: HARRIS MH, EDGAR M, MEGHJI S, eds. Clinical oral science. Oxford, UK: Wright, 1998; 120-133.
4. GROUNDS MD, MCGEACHIE JK, DAVIES MJ, SOROKIN LM, MALEY MAL. The expression of extracellular matrix during adult skeletal muscle regeneration: how the basement membrane, interstitium and myogenic cells collaborate. Basic Appl Myol 1998; 8: 129-141.
5. COPE JB, SAMCHUKOV ML, CHERKASHIN AM. Mandibular distraction osteogenesis: a historic perspective and future directions. Am J Orthod Dentofac Orthop 1999; 115: 448-460.
6. DE DEYNE PG, HAYATSU K, MEYER R, PALEY D, HERZENBERG JE. Muscle regeneration and fiber-type transformation during distraction osteogenesis. J Orthop Res 1999; 17: 560-570.
7. PROFFIT WR, WHITE RP. Long-Face problems. In: PROFFIT WR, WHITE RP, eds. Surgical-orthodontic treatment. London: Mosby Year Book, 1991; 381-427.
8. PROFFIT WR, BAILEY LJ, PHILLIPS C, TURVEY TA. Long-term stability of surgical open-bite correction by Le Fort I osteotomy. Angle Orthod 2000; 70: 112-117.
9. WEDDEN SE, RALPHS JR, TICKLE C. Pattern formation in the facial primordia. Development 1988; 103 (Suppl): 31-40.
10. NODEN DM. An analysis of migratory behaviour of avian cephalic neural crest cells. Dev Biol 1975; 42: 106-130.
11. NODEN DM. The embryonic origins of avian cephalic and cervical muscles and associated connective tissues. Am J Anat 1983; 168: 257-276.
12. NODEN DM. Interactions and fates of avian craniofacial mesenchyme. Development 1988; 103 (Suppl): 121-140.
13. MILLER JB, SCHAEFER L, DOMINOV JA. Seeking muscle stem cells. Curr Top Dev Biol 1999; 43: 191-219.
14. STREULI C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 1999; 11: 634-640.
15. VELLEMAN SG. The role of the extracellular matrix in skeletal muscle development. Poult Sci 1999; 78: 778-784.
16. BISCHOFF R. The satellite cell and muscle regeneration. In: ENGEL AG, FRANZINI-ARMSTRONG C, eds. Myology. Vol. 2. New York: McGraw-Hill, 1994: 97-118.
17. KATZ FRS. The termination of the afferent nerve fibre in the muscle spindle of the frog. Phil Trans Roy Soc Lond 1961; 243: 221-225.
18. MAURO AJ. Satellite cells of skeletal muscle fibre. J Biophys Biochem Cytol 1961; 9: 493-495.
19. SCHULTZ E. Satellite cell behaviour during skeletal muscle growth and regeneration. Med Sci Sports Exerc 1989; 21: S181-186.
20. SCHULTZ E. Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol 1996; 175: 84-94.
21. SEALE P, RUDNICKI A. A new look at the origin, function and "stem-cell" status of muscle satellite cells. Dev Biol 2000; 218: 115-124.
22. GROUNDS MD. Towards understanding skeletal muscle regeneration. Pathol Res Pract 1991; 187: 1-22.
23. FERRARI G, CUSELLA-DE ANGELIS G, COLETTA M, PAOLUCCI E, STORNAIUOLO A, COSSU G, MAVILIO F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-1530.
24. SANES JR. The extracellular matrix. In: ENGEL AG, FRANZINI-ARMSTRONG C, eds. Myology. Vol. 2. New York: McGraw-Hill, 1994; 242-260.
25. PAVLATH GK, THALOOR D, RANDO TA, CHEONG M, ENGLISH AW, ZHENG B. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev Dyn 1998; 212: 495-508.
26. MCMINN RMH. Last's anatomy: regional and applied, 9th edition. Edinburgh: Churchill Livingstone, 1995; 455.
27. BORG TK, CAULFIELD JB. Morphology of connective tissue in skeletal muscle. Tissue Cell 1980; 12: 197-207.
28. LEESON TS, LEESON CR, PAPARO AA. Text/atlas of histology, 1st edition. London: WB Saunders, 1988; 237.
29. HENRY MD, CAMPBELL KP. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996; 8: 625-631.
30. KATZ BZ, YAMADA KM. Integrins in morphogenesis and signaling. Biochimie 1997; 79: 467-476.
31. BISCHOFF R. Regeneration of single skeletal muscle fibers in vitro. Anat Rec 1975; 182: 215-235.
32. GULATI AK, REDDI AH, ZALEWSKI AA. Changes in the basement membrane zone components during skeletal muscle fiber degeneration and regeneration. J Cell Biol 1983; 97: 957-962.
33. GROUNDS MD. Muscle regeneration: molecular aspects and therapeutic implications. Curr Opin Neurol 1999; 12: 535-543.
34. SANES JR, MARSHALL LM, MCMAHAN UJ. Reinnervation of muscle fiber basal lamina after removal of myofibers. Differentiation of regenerating axons at original synaptic sites. J Cell Biol 1978; 78: 176-198.
35. GLICKSMAN MA, SANES JR. Differentiation of motor nerve terminals formed in the absence of muscle fibres. J Neurocytol 1983; 12: 661-671.
36. PATTON BL, MINER JH, CHIU AY, SANES JR. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol 1997; 139: 1507-1521.
37. FRISDAL E, TEIGER E, LEFAUCHEUR JP, ADNOT S, PLANUS E, LAFUMA C, D'ORTHO MP. Increased expression of gelatinases and alteration of basement membrane in rat soleus muscle following femoral artery ligation. Neuropathol Appl Neurobiol 2000; 26: 11-21.
38. RAMPOLDI E, MEOLA G, CONTI AM, VELICOGNA M, LARIZZA L. A comparative analysis of collagen III, IV, laminin and fibronectin in Duchenne muscular dystrophy biopsies and cell cultures. Eur J Cell Biol 1986; 42: 27-34.
39. QUIRICO-SANTOS T, RIBEIRO MM, SAVINO W. Increased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion. J Neuroimmunol 1995; 59: 9-18.
40. SCHULER F, SOROKIN LM. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Sci 1995; 108: 3795-3805.
41. RINGELMANN B, RODER C, HALLMANN R, MALEY M, DAVIES M, GROUNDS M, SOROKIN L. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp Cell Res 1999; 246: 165-182.
42. BATESON DS, PARRY DJ. Motor units in a fast-twitch muscle of normal and dystrophic mice. J Physiol 1983; 345: 515-523.
43. EDWARDS JP, HATTON PA, WAREHAM AC. Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57BL/6J dy2J/dy2J dystrophic mouse. Brain Res 1998; 788: 262-268.
44. LAW PK, SAITO A, FLEISCHER S. Ultrastructural changes in muscle and motor end-plate of the dystrophic mouse. Exp Neurol 1983; 80: 361-382.
45. TREMBLAY JP, GREGOIRE L, SASSEVILLE R, GUAY G, BELHUMEUR C. Reduction of postjunctional fold density and depth in dystrophic mice. Synapse 1988; 2: 148-156.
46. KAARIAINEN M, KAARIAINEN J, JARVINEN TLN, NISSINEN L, HEINO J, JARVINEN M, KALIMO H. Integrin and dystrophin associated adhesion protein complexes during regeneration of shearing-type muscle injury. Neuromusc Disord 2000; 10: 121-132.
47. SOROKIN LM, MALEY MAL, MOCH H, VON DER MARK H, VON DER MARK K, CADALBERT L, KAROSI S, DAVIES MJ, MCGEACHIE JK, GROUNDS MD. Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury. Exp Cell Res 2000; 256: 500-514.
48. TOME FMS, EVANGELISTA T, LECLERC A, SUNADA Y, MANOLE E, ESTOURNET B, BAROIS A, CAMPBELL KP, FARDEAU M. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994; 317: 351-357.
49. HELBLING-LECLERC A, ZHANG X, TOPALOGLU H, CRUAUD C, TESSON F, WEISSENBACH J, TOME FMS, SCHWARTZ K, FARDEAU M, TRYGGVASON K, GUICHENEY P. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11: 216-218.
50. PEGORARO E, MARKS H, GARCIA CA, CRAWFORD T, MANCIAS P, CONNOLLY AM, FANIN M, MARTINELLO F, TREVISAN CP, ANGELINI C, STELLA A, SCAVINA M, MUNK RL, SERVIDEI S, BONNEMANN CC, BERTORINI T, ACSADI G, THOMPSON CE, GAGNON D, HOGANSON G, CARVER V, ZIMMERMAN RA, HOFFMAN EP. Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 1998; 51: 101-110.
51. COHN RD, HERRMANN R, SOROKIN L, WEWER UM, VOIT T. Laminin alpha2 chain-deficient congenital muscular dystrophy: variable epitope expression in severe and mild cases. Neurology 1998; 51: 94-100.
52. COLOGNATO H, YURCHENCO PD. Form and function: the laminin family of heterotrimers. Dev Dyn 2000; 218: 213-234.
53. HALTIA M, LEIVO I, SOMER H, PIHKO H, PAETAU A, KIVELA T, TARKKANEN A, TOME F, ENGVALL E, SANTAVUORI P. Muscle-eye-brain disease: a neuropathological study. Ann Neurol 1997; 41: 173-180.
54. KANOFF RJ, CURLESS RG, PETITO C, FALCONE S, SIATKOWSKI RM, PEGORARO E. Walker-Warburg syndrome: neurologic features and muscle membrane structure. Pediatr Neurol 1998; 18: 76-80.
55. AURANEN M, RAPOLA J, PIHKO H, HALTIA M, LEIVO I, SOINILA S, VIRTANEN I, KALIMO H, ANDERSON LV, SANTAVUORI P, SOMER H. Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease. Neuromusc Disord 2000; 10: 16-23.
56. GROUNDS MD. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann N Y Acad Sci 1998; 854: 78-91.
57. SEWRY CA, CHEVALLAY M, TOME FMS. Expression of laminin subunits in human fetal skeletal muscle. Histochem J 1995; 27: 497-504.
58. SEWRY CA, PHILPOT J, MAHONY D, WILSON LA, MUNTONI F, DUBOWITZ V. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995; 5: 307-316.
59. TOME FMS, GUICHENEY P, FARDEAU M. Congenital muscular dystrophies. In: EMERY AEH, ed. Neuromuscular disorders. Clinical and molecular genetics. Chichester, UK: Wiley, 1998.
60. MERLINI L, VILLANOVA M, SABATELLI P, MALANDRINI A, MARALDI NM. Decreased expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy. Neuromusc Disord 1999; 9: 326-329.
61. TAYLOR J, MUNTONI F, ROBB S, DUBOWITZ V, SEWRY C. Early onset autosomal dominant myopathy with rigidity of the spine: a possible role for laminin beta 1. Neuromusc Disord 1997; 7: 211-216.
62. LI M, DICKSON DW, SPIRO AJ. Abnormal expression of laminin beta 1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. Arch Neurol 1997; 109: 1457-1461.
63. PATTON BL, CONNOLL AM, MARTIN PT, CUNNINGHAM JM, MEHTA S, PESTRONK A, MINER JH, SANES JR. Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromusc Disord 1999; 9: 423-433.
64. NOAKES PG, GAUTAM M, MUDD J, SANES JR, MERLIE JP. Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin beta 2. Nature 1995; 374: 258-262.
65. VILLANOVA M, SABATELLI P, HE Y, MALANDRINI A, PETRINI S, MARALDI NM, MERLINI L. Immunofluorescence study of a muscle biopsy from a 1-year-old patient with Walker-Warburg syndrome. Acta Neuropathol 1998; 96: 651-654.
66. WEWER UM, DURKIN ME, ZHANG X, LAURSEN H, NIELSEN NH, TOWFIGHI J, ENGVALL E, ALBRECHTSEN R. Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology 1995; 45: 2099-2101.
67. GULLBERG D, VELLING T, SJOBERG G, SALMIVIRTA K, GAGGERO B, TIGER CF, EDSTROM L, SEJERSEN T. Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis. Neuromusc Disord 1997; 7: 39-54.
68. BURCH GH, BEDOLLI MA, MCDONOUGH S, ROSENTHAL SM, BRISTOW J. Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development. Dev Dyn 1995; 203: 491-504.
69. JOBSIS GJ, KEIZERS H, VREIJLING JP, DE VISSER M, SPEER MC, WOLTERMAN RA, BAAS F, BOLHUIS PA. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat Genet 1996; 14: 113-115.
70. PAN TC, ZHANG RZ, PERICAK-VANCE MA, TANDAN R, FRIES T, STAJICH JM, VILES K, VANCE JM, CHU ML, SPEER MC. Missence mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy. Hum Mol Genet 1998; 7: 807-812.
71. DESGRANGES P, BARBAUD C, CARUELLE JP, BARRITAULT D, GAUTRON J. A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle. FASEB J 1999; 13: 761-766.
72. WEWER UM, IBA K, DURKIN ME, NIELSEN FC, LOECHEL F, GILPIN BJ, KUANG W, ENGVALL E, ALBRECHTSEN R. Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol 1998; 200: 247-259.
73. CARRINO DA. Dynamic expression of proteoglycans during skeletal muscle development. Basic Appl Myol 1998; 8: 95-106.
74. CARRINO DA, SORRELL JM, CAPLAN AI. Dynamic expression of proteoglycans during skeletal muscle development and maturation. Poult Sci 1999; 78: 769-777.
75. CACERES S, CUELLAR C, CASAR JC, GARRIDO J, SCHAEFER L, KRESSE H, BRANDAN E. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur J Cell Biol 2000; 79: 173-181.
76. PRICE N, HUNT NP, LEWIS MP. Expression of an embryonic fibronectin splicing variant in human masseter muscle [published erratum appears in Arch Oral Biol 1999; 44: I]. Arch Oral Biol 1998; 43: 911-915.
77. HAGIOS C, BROWN-LUEDI M, CHIQUET-EHRISMANN R. Tenascin-Y, a component of distinctive connective tissues, supports muscle cell growth. Exp Cell Res 1999; 253: 607-617.
78. RAO JS, BEACH RL, FESTOFF BW. Extracellular-matrix (ECM) synthesis in muscle-cell cultures-quantitative and qualitative studies during myogenesis. Biochem Biophys Res Commun 1985; 440-446.
79. VON DER MARK K, OCALAN M. Antagonistic effects of laminin and fibronectin on the expression of the myogenic phenotype. Differentiation 1989; 150-157.
80. OCALAN M, GOODMAN SL, KUHL U, HAUSCHKA SD, VON DER MARK K. Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. Dev Biol 1988; 125: 158-167.
81. KUHL U, OCALAN M, TIMPL R, VON DER MARK K. Role of laminin and fibronectin in selecting myogenic versus fibrogenic cells from skeletal muscle cell in vitro. Dev Biol 1986; 117: 628-635.
82. VACHON PH, LOECHEL F, XU H, WEWER UM, ENGVALL E. Merosin and laminin in myogenesis-specific requirement for merosin in myotube stability and survival. J Cell Biol 1996; 134: 1483-1497.
83. YAO CC, ZIOBER BL, SUTHERLAND AE, MENDRICK DL, KRAMER RH. Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. J Cell Sci 1996; 109: 3139-3150.
84. GOODMAN SL, DEUTZMANN R, NURCOMBE V. Locomotory competence and laminin-specific cell surface binding sites are lost during myoblast differentiation. Development 1989; 106: 795-802.
85. MALEY MAL, DAVIES MJ, GROUNDS MD. Extracellular-matrix, growth-factors, genetics - their influence on cell proliferation and myotube formation in primary cultures of adult-mouse skeletal muscle. Exp Cell Res 1995; 219: 169-179.
86. PRIMAKOFF P, MYLES DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 2000; 16: 83-87.
87. KAUFMANN U, MARTIN B, LINK D, WITT K, ZEITLER R, REINHARD S, STARZINSKIPOWITZ A. M-cadherin and its sisters in development of striated muscle. Cell Tissue Res 1999; 296: 191-198.
88. CHARLTON CA, MOHLER WA, BLAU HM. Neural cell adhesion molecule (NCAM) and myoblast fusion. Dev Biol 2000; 221: 112-119.
89. ROSEN GD, SANES JR, LACHANTE R, CUNNINGHAM JM, ROMAN J, DEAN DC. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 1992; 69: 1107-1119.
90. MICHALAK M, OPAS M. Functions of dystrophin and dystrophin associated proteins. Curr Opin Neurol 1997; 10: 436-442.
91. KREIBORG S, LETH JENSEN B, MOLLER E, BJORK A. Craniofacial growth in a case of congenital muscular dystrophy. A roentgencephalometric and electromyographic investigation. Am J Orthod 1978; 74: 207-215.
92. KILIARIDIS S, KATSAROS C. The effects of myotonic and Duchenne muscular dystrophy on the orofacial muscles and dentofacial morphology. Acta Odontol Scand 1998; 56: 369-374.
93. SCHENDEL SA, EISENFELD J, BELL WH, EPKER BN, MISCHELVICH DJ. The long face syndrome: vertical maxillary excess. Am J Orthod 1976; 70: 398-408.
94. SONG WK, WANG W, FOSTER RF, BIELSER DA, KAUFMAN SJ. H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis [published erratum appears in J Cell Biol 1992; 118: 213]. J Cell Biol 1992; 117: 643-657.
95. ZIOBER BL, VU MP, WALEH N, CRAWFORD J, LIN CS, KRAMER R. Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development. J Biol Chem 1993; 268: 26773-26783.
96. SASTRY SK, LAKONISHOK M, THOMAS DA, MUSCHLER J, HORWITZ AF. Integrin alpha-subunit ratios, cytoplasmic domains, and growth-factor synergy regulate muscle proliferation and differentiation. J Cell Biol 1996; 133: 169-184.
97. VAN DER FLIER A, KUIKMAN I, BAUDOIN C, VANDERNEUT R, SONNENBERG AA. Novel beta-1 integrin isoform produced by alternative splicing - unique expression in cardiac and skeletal-muscle. FEBS Lett 1995; 369: 340-344.
98. ZHIDKOVA NI, BELKIN AM, MAYNE R. Novel isoform of beta 1 integrin expressed in skeletal and cardiac muscle. Biochem Biophys Res Commun 1995; 214: 279-285.
99. BELKIN AM, ZHIDKOVA NI, BALZAC F, ALTRUDA F, TOMATIS D, MAIER A, TARONE G, KOTELIANSKY VE, BURRIDGE K. Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells. J Cell Biol 1996; 132: 211-226.
100. GIANCOTTI FG, RUOSLAHTI E. Transduction - integrin signaling. Science 1999; 285: 1028-1032.
101. DISATNIK MH, RANDO TA. Integrin-mediated muscle cell spreading - the role of protein kinase C in outside-in and inside-out signaling and evidence of integrin cross-talk. J Biol Chem 1999; 274: 32486-32492.
102. DUBAND JL, BELKIN AM, SYFRIG J, THIERY JP, KOTELIANSKY VE. Expression of alpha 1 integrin, a laminin-collagen receptor, during myogenesis and neurogenesis in the avian embryo. Development 1992; 116: 585-600.
103. GULLBERG D, VELLING T, SJOBERG G, SEJERSEN T. Up-regulation of a novel integrin alpha-chain (alpha (mt)) on human fetal myotubes. Dev Dyn 1995; 204: 57-65.
104. YANG JT, RANDO TA, MOHLER WA, RAYBURN H, BLAU HM, HYNES RO. Genetic analysis of alpha 4 integrin functions in the development of mouse skeletal muscle. J Cell Biol 1996; 135: 829-835.
105. TAVERNA D, DISATNIK MH, RAYBURN H, BRONSON RT, YANG J, RANDO TA, HYNES RO. Dystrophic muscle in mice chimeric for expression of alpha5 integrin. J Cell Biol 1998; 143: 849-859.
106. BURKIN DJ, KAUFMAN SJ. The alpha 7 beta 1 integrin in muscle development and disease. Cell Tissue Res 1999; 296: 183-190.
107. HODGES BL, HAYASHI YK, NONAKA I, WANG W, ARAHATA K, KAUFMAN SJ. Altered expression of the α7β1 integrin in human and murine muscular dystrophies. J Cell Sci 1997; 110: 2873-2881.
108. HAYASHI YK, CHOU FL, ENGVALL E, OGAWA M, MATSUDA C, HIRABAYASHI S, YOKOCHI K, ZIOBER BL, KRAMER RH, KAUFMAN SJ, OZAWA E, GOTO Y, NONAKA I, TSUKAHARA T, WANG JZ, HOFFMAN EP, ARAHATA K. Mutations in the integrin alpha 7 gene cause congenital myopathy. Nature Genetics 1998; 19: 94-97.
109. MAYER U, SAHER G, FASSLER R, BORNEMANN A, ECHTERMEYER F, VON DER MARK H, MIOSGE N, POSCHL E, VON DER MARK K. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat Genet 1997; 17: 318-323.
110. PALMER EL, RUEGG C, FERRANDO R, PYTELA R, SHEPPARD D. Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle [published erratum appears in J Cell Biol 1994; 124: 395]. J Cell Biol 1993; 123: 1289-1297.
111. VELLING T, KUSCHE GULLBERG M, SEJERSEN T, GULLBERG D. cDNA cloning and chromosomal localization of human alpha (11) integrin - a collagen-binding, I domain-containing, beta (1-)associated integrin alpha-chain present in muscle tissues. J Biol Chem 1999; 274: 25735-25742.
112. HIRSCH E, GULLBERG D, BALZAC F, ALTRUDA F, SILENGO L, TARONE G. Alpha (v) integrin subunit is predominantly located in nervous-tissue and skeletal-muscle during mouse development. Dev Dyn 1994; 201: 108-120.
113. HIRSCH E, LOHIKANGAS L, GULLBERG D, JOHANSSON S, FASSLER R. Mouse myoblasts can fuse and form a normal sarcomere in the absence of beta1 integrin expression. J Cell Sci 1998; 111: 2397-2409.
114. BRAKEBUSCH C, HIRSCH E, POTOCNIK A, FASSLER R. Genetic analysis of beta1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules. J Cell Sci 1997; 110: 2895-2904.
115. DE DEYNE PG, O'NEILL A, RESNECK WG, DMYTRENKO GM, PUMPLIN DW, BLOCH RJ. The vitronectin receptor associates with clathrin-coated membrane domains via the cytoplasmic domain of its beta5 subunit. J Cell Sci 1998; 111: 2729-2740.
116. BLASCHUK KL, GUERIN C, HOLLAND PC. Myoblast alpha v beta 3 integrin levels are controlled by transcriptional regulation of expression of the beta 3 subunit and downregulation of beta 3 subunit expression is required for skeletal muscle cell differentiation. Dev Biol 1997; 184: 266-277.
117. DILULLO C, MENKO AS, PHILP NJ, MATTIOLI P, GILHOOL P, MCGINLEY C, BOETTIGER D. A novel periodic localization for alpha 1 integrin in skeletal muscle. Basic Appl Myol 1998; 8: 325-340.
118. GULLBERG D, SJOBERG G, VELLING T, SEJERSEN T. Analysis of fibronectin and vitronectin receptors on human fetal skeletal-muscle cells upon differentiation. Exp Cell Res 1995 2; 220: 112-123.
119. MCDONALD KA, LAKONISHOK M, HORWITZ AF. Alpha (v) and alpha (3) integrin subunits are associated with myofibrils during myofibrillogenesis. J Cell Sci 1995; 108: 2573-2581.
120. ENOMOTO MI, BOETTIGER D, MENKO AS. Alpha 5 integrin is a critical component of adhesion plaques in myogenesis. Dev Biol 1993; 155: 180-197.
121. SASTRY SK, LAKONISHOK M, WU S, TRUONG TQ, HUTTENLOCHER A, TURNER CE, HORWITZ AF. Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal. J Cell Biol 1999; 144: 1295-1309.
122. BLASCHUK KL, HOLLAND PC. The regulation of alpha (5) beta (1) integrin expression in human muscle-cells. Dev Biol 1994; 164: 475-483.
123. BIRKEDAL-HANSEN H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 7: 728-735.
124. BASBAUM CB, WERB Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix at the cell surface. Curr Opin Cell Biol 1996; 8: 731-738.
125. WERB Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91: 439-442.
126. THOMAS GJ, LEWIS MP, SPEIGHT PM. Matrix metalloproteinases and oral cancer. Oral Oncol 1999; 35: 227-233.
127. NAGASE H, WOESSNER JF. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
128. WOESSNER JF, NAGASE H. Matrix metalloproteinases and TIMPs, 1st edition. Oxford, UK: Oxford University Press, 2000.
129. SINGH A, NELSON-MOON Z, THOMAS GJ, HUNT NP, LEWIS MP. Identification of matrix metalloproteinases and their tissue inhibitors type 1 and 2 in human masseter muscle. Arch Oral Biol 2000; 45: 431-440.
130. BENDIKT G, SCHOSER H, BLOTTNER D. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle. Neuroreport 1999; 10: 2795-2797.
131. KHERIF S, DEHAUPAS M, LAFUMA C, FARDEAU M, ALAMEDDINE HS. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve. Neuropathol Appl Neurobiol 1998; 24: 309-319.
132. KHERIF S, LAFUMA C, DEHAUPAS M, LACHKAR S, FOURNIER JG, VERDIERE-SAHUQUE M, FARDEAU M, ALAMEDDINE HS. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 1999; 205: 158-170.
133. CHOI YC, DALAKAS MC. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 2000; 54: 65-71.
134. LEWIS MP, TIPPETT HL, SINANAN ACM, MORGAN MJ, HUNT NP. Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures. J Musc Res Cell Motil 2000; 21: 223-233.
135. GUERIN CW, HOLLAND PC. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells. Dev Dyn 1995; 202: 91-99.
136. EL FAHIME E, TORRENTE Y, CARON NJ, BRESOLIN MD, TREMBLAY JP. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 2000; 258: 279-287.
137. CARON N, ASSELIN I, MOREL G, TREMBLAY J. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant 1999; 8: 456-476.
138. CHIN JR, WERB Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 1997; 124: 1519-1530.
139. SIMPSON AH, WILLIAMS PE, KYBERD P, GOLDSPINK G, KENWRIGHT J. The response of muscle to leg lengthening. J Bone Joint Surg Br 1995; 77: 630-636.
140. WILLIAMS P, KYBERD P, SIMPSON H, KENWRIGHT J, GOLDSPINK G. The morphological basis of increased stiffness of rabbit anterior muscles during surgical limb-lengthening. J Anat 1998; 193: 131-138.
141. WILLIAMS P, SIMPSON H, KYBERD P, KENWRIGHT J, GOLDSPINK G. Effect of rate of distraction on loss of joint movement, muscle stiffness, and intramuscular connective tissue content during surgical limb-lengthening: a study in the rabbit. Anat Rec 1999; 255: 78-83.
142. DE DEYNE PG, MEYER R, PALEY D, HERZENBERG JE. The adaptation of perimuscular connective tissue during distraction osteogenesis. Clin Orthop 2000; 379: 259-269.